Kidney Patients and the Safe Use of Lidocaine Patches: A Comprehensive Guide

Living with chronic kidney disease (CKD) can be challenging, but advancements in medical technology and treatment offer hope. One such advancement is the prescription lidocaine transdermal patch, commonly known as Lidoderm. This article aims to provide a comprehensive guide on whether a kidney patient can use lidocaine patches safely and effectively.

Prescription lidocaine transdermal comes in two forms: the Dermalid Lidoderm 5% patch, and the zTlido 1.8% topical system. These preparations are intended to relieve pain by applying the medication directly to the skin. However, like any medication, it is crucial to follow the instructions carefully to ensure safe and effective treatment.

Understanding Lidocaine Patches

Lidocaine transdermal patches are designed for the treatment of nerve pain, also known as neuralgia, and can provide temporary pain relief. They offer a continuous, low-level dose of the drug, which is absorbed through the skin and distributed systemically. The patches are designed to be applied only once a day, as needed for pain. It is essential not to exceed three patches or three applications of the topical system at one time, and never wear a patch for more than 12 hours per day, with at least a 12-hour break between applications.

Care and Considerations for Kidney Patients

For individuals with chronic kidney disease, it is particularly important to monitor the use of medications carefully to avoid potential complications. Lidocaine patches are generally considered safe for use in CKD patients, but it is crucial to consult with your healthcare provider before starting any new treatment regimen.

One patient's story illustrates the positive impact such treatments can have. They shared, 'I thought chronic kidney disease was a life sentence. I was wrong! What my doctor told me about CKD blew my mind… but then I did what he told me – and I realized he was right!' This emphasizes the importance of staying informed and actively engaging with medical professionals to manage CKD effectively.

Patch Composition and Application

The Lidoderm patch is composed of an adhesive material containing 5% lidocaine. This is applied to a non-woven polyester felt backing and is covered with a polyethylene terephthalate (PET) film release liner. The release liner must be removed prior to applying the patch to the skin. Each patch measures 10 cm x 14 cm.

For those using lidocaine patches, it is important to follow the directions provided on your prescription label carefully. This includes the frequency and duration of application, as well as any necessary breaks between applications. Always consult with your doctor or pharmacist if you have any questions or concerns about your treatment plan.

Experiences and Disorders

In some cases, long-term use of lidocaine patches or creams has been associated with tissue compromise and bleeding around needles during treatments. However, one patient who has used the lidocaine cream for 17 years with one fistula and 7 years with a different fistula in their dominant arm reported no reoccurring issues. They noted that over time, they no longer felt the needle sticks, suggesting that the numbness from the lidocaine could provide significant relief.

Another aspect to consider is the immunosuppressant regimen being used by the patient. If you are on a regimen like Gengraf, CellCept, and Prednisone, it is essential to discuss with your transplant team to ensure that the use of lidocaine patches or cream is appropriate and safe for your specific condition.

Conclusion

In summary, while no definitive answer can be given without considering an individual's specific medical history and current condition, kidneys patients can safely use lidocaine patches under the guidance of a healthcare provider. It is crucial to follow all instructions provided and to maintain open communication with your doctor to ensure the best outcomes. Remember, staying informed and proactive in your health management is key to living well with CKD.